Sigma Pharmaceuticals Ltd in Retailing (Australia)
After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals entered into a memorandum of understanding with Pharmacy Alliance to open 30 new Amcal stores, with more in the pipeline. It also announced additional investment in key retail initiatives including the improvement of its multichannel and social media platforms, an upgrade of the loyalty platform...
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Non-Store Retailing, Store-based Retailing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Non-Store Retailing, Store-based Retailing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Retailing market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Strategic Direction
Key Facts
Summary 1 Sigma Pharmaceuticals Limited: Key Facts
Summary 2 Sigma Pharmaceuticals Limited: Operational Indicators
Internet Strategy
Summary 3 Sigma Pharmaceuticals Limited: Share of Sales Generated by Internet Retailing
Company Background
Private Label
Summary 4 Sigma Pharmaceuticals Limited: Private Label Portfolio
Competitive Positioning
Summary 5 Sigma Pharmaceuticals Limited: Competitive Position 2013
Key Facts
Summary 1 Sigma Pharmaceuticals Limited: Key Facts
Summary 2 Sigma Pharmaceuticals Limited: Operational Indicators
Internet Strategy
Summary 3 Sigma Pharmaceuticals Limited: Share of Sales Generated by Internet Retailing
Company Background
Private Label
Summary 4 Sigma Pharmaceuticals Limited: Private Label Portfolio
Competitive Positioning
Summary 5 Sigma Pharmaceuticals Limited: Competitive Position 2013